In July 2003, the National Institute of Child Health and Human Development convened a conference, “Research on Prevention of Bilirubin-Induced Brain Injury and Kernicterus: Bench-to-Bedside.” This article will provide a summary of presentations and discussions from this conference. The summary will focus on the identified knowledge gaps in 5 areas related to bilirubin-induced brain injury and kernicterus: 1) neurobiology and neuroimaging; 2) epidemiology and issues of clinical management; 3) methodologies for assessing clinical jaundice and direct and noninvasive measurement of serum bilirubin and hemolysis; 4) therapies for management of neonatal hyperbilirubinemia; and 5) public health surveillance and systems-based approaches to prevention.

You do not currently have access to this content.